Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Falch

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1995
Bone mass in non-insulin-dependent diabetes mellitusU Rishaug, K I Birkeland, J A Falch, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 29, 2000
Factors associated with mortality after hip fractureH E Meyer, A Tverdal, J A Falch, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 16, 2010
Outdoor air pollution, bone density and self-reported forearm fracture: the Oslo Health StudyK Alver, H E Meyer, J A Falch, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1995
There is no difference in spontaneous and 17 beta-estradiol-induced interleukin-1 beta release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone lossA K Høgåsen, L Nordsletten, A O Aasen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 20, 1998
17 beta-Oestradiol and 1 alpha,25-dihydroxycholecalciferol modulate constitutive and bone matrix-induced interleukin-1 beta (IL-1 beta) production by peripheral blood mononuclear cells isolated from postmenopausal womenA K Høgåsen, L Nordsletten, A O Aasen, et al.
Bone|July 27, 2001
Osteoporosis in the Norwegian mooseR Bjorå, J A Falch, H Staaland, et al.
Acta Medica Scandinavica|January 1, 1987
Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferolJ A Falch, O R Odegaard, A M Finnanger, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Normal bone mass in bulimic womenJ Sundgot-Borgen, R Bahr, J A Falch, et al.
Bone|October 1, 1995
Height and body mass index in Oslo, Norway, compared to other regions of Europe: do they explain differences in the incidence of hip fracture? European Vertebral Osteoporosis Study GroupH E Meyer, J A Falch, T O'Neill, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 20, 2008
Change in the use of hormone replacement therapy and the incidence of fracture in OsloH E Meyer, C M Lofthus, A J Søgaard, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1995
Bone mass in non-insulin-dependent diabetes mellitusU Rishaug, K I Birkeland, J A Falch, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 29, 2000
Factors associated with mortality after hip fractureH E Meyer, A Tverdal, J A Falch, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 16, 2010
Outdoor air pollution, bone density and self-reported forearm fracture: the Oslo Health StudyK Alver, H E Meyer, J A Falch, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1995
There is no difference in spontaneous and 17 beta-estradiol-induced interleukin-1 beta release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone lossA K Høgåsen, L Nordsletten, A O Aasen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 20, 1998
17 beta-Oestradiol and 1 alpha,25-dihydroxycholecalciferol modulate constitutive and bone matrix-induced interleukin-1 beta (IL-1 beta) production by peripheral blood mononuclear cells isolated from postmenopausal womenA K Høgåsen, L Nordsletten, A O Aasen, et al.
Bone|July 27, 2001
Osteoporosis in the Norwegian mooseR Bjorå, J A Falch, H Staaland, et al.
Acta Medica Scandinavica|January 1, 1987
Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferolJ A Falch, O R Odegaard, A M Finnanger, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Normal bone mass in bulimic womenJ Sundgot-Borgen, R Bahr, J A Falch, et al.
Bone|October 1, 1995
Height and body mass index in Oslo, Norway, compared to other regions of Europe: do they explain differences in the incidence of hip fracture? European Vertebral Osteoporosis Study GroupH E Meyer, J A Falch, T O'Neill, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 20, 2008
Change in the use of hormone replacement therapy and the incidence of fracture in OsloH E Meyer, C M Lofthus, A J Søgaard, et al.
Pageof 10